This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

DIRECTV can't show 'likelihood of success' to block deal in US, Nexstar, Tegna say

( March 24, 2026, 14:00 GMT | Official Statement) -- MLex Summary: DIRECTV's motion to prevent TV news provider Nexstar Media Group from integrating acquisition target Tegna into its operations even though the deal has already closed should be denied, Nexstar and Tegna told a US federal district court. "Plaintiff’s speculative claims that it will be forced to raise rates on its own customers, or that those customers will receive lower quality news, are both unsupported and irrelevant," the defendants wrote. "Again, among other reasons, the FCC Order commits Nexstar to expand local journalism and programming, just as it has done after prior deals. Beyond the lack of immediate, irreparable harm—which is enough for the Court to deny a TRO—the Court should also decline to issue a TRO because DIRECTV has not established a likelihood of success on the merits."See attached document....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login